Global non-opioid pain treatment market

SKU ID : MMR- 13386100

Publishing Date : 08-Apr-2019

No. of pages : 290

PRICE
4100
6000

  • Global non-opioid pain treatment market was valued US$ 3.8 Bn in 2017 and is expected to reach US$ 4.84 Bn by 2026, at a CAGR of 3.07 % during a forecast period.



    The major driving factors of the global non-opioid pain treatment market are rising geriatric population and easy & effective medications of non-opioids drugs for cancer treatment. Better healthcare facilities and the availability of sophisticated treatment options have improved life expectation rates globally is also boosting the growth of the market. However, preference for alternative therapies, and fake products are limiting the market growth.

    Arthritis is one of the most common indications of non-opioid pain management and it is an informal way of referring to joint pain or joint disease. Neuropathic pain is a prominent form of pain related to a wide variety of common diseases & situations including cancer, and diabetes.
    Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium clostridium botulinum bacteria. Botulinum toxin is used to treat certain eye disorders such as crossed eyes i.e. strabismus, uncontrolled blinking to treat muscle stiffness & spasms and to reduce the cosmetic appearance of wrinkles.

    Capsaicin is used in medicated creams and lotions such as topical ointments, nasal sprays, and dermal patches to relieve pain. They may reduce your appetite and help lower blood pressure.

    Asia-Pacific is expected to be the fastest-growing region for the global non-opioid pain treatment market. China, Japan, and India are the leading countries for non-opioid pain drugs owing to the high demand for better health management & economic conditions and growing awareness about pain medication. In addition, the growing ageing population in the Asia-Pacific region is also increasing the growth of the non-opioid pain treatment market.

    The major market players of the global non-opioid pain treatment market are Allergan Plc., Aurora Cannabis Enterprises Inc., Canopy Growth Corp., GW Pharmaceuticals, and Tilray.

    The report covers a comprehensive study of major market drivers, restrains, opportunities, challenges, PESTEL, Porters, SWOT, and technological forecasting in the market.
    The Scope of Global Non-Opioid Pain Treatment Market:
    Global Non-Opioid Pain Treatment Market, by Products:
    Medical Cannabis
    Menthol-Containing
    Omega 3 Fatty Acid-Containing
    Botulinum Toxins
    Capsaicin-Derived
    Global Non-Opioid Pain Treatment Market, by Therapeutic Applications:
    Orthopaedic & Musculoskeletal Pain
    Neuropathic Pain
    Cancer Pain
    Other Pain
    Global Non-Opioid Pain Treatment Market, by Region:
    North America
    Europe
    Asia-Pacific
    South America
    Middle East & Africa
    Key Player Operating In the Global Non-Opioid Pain Treatment Market:
    Allergan PLC
    Aphria Inc.
    Aurora
    Bedrocan
    Canopy Growth Corp.
    Cara Therapeutics
    Centrexion Therapeutics
    CHT Medical
    Cronos Group
    GW Pharmaceuticals
    Medical Marijuana Inc.
    Medropharm Gmbh
    Panag Pharma Inc.
    Tilray
    US Worldmeds LLC
    Vanway


    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports